Neumora Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized for Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Neumora Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate for Q3 2023.
  • Neumora Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending September 20, 2023 was 50M shares.
Preferred Stock, Shares Authorized, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 50M Sep 20, 2023 10-Q 2024-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.